IDiyas

For the Inventor, By the Inventor

Sandwich, United Kingdom

Stephen Paul Gibson

USPTO Granted Patents = 20 


Average Co-Inventor Count = 3.5

ph-index = 6

Forward Citations = 221(Granted Patents)


Location History:

  • Margate, GB (1990 - 1992)
  • New York, NY (US) (1995 - 1998)
  • Westbrook, GB (1992 - 2002)
  • Kent, GB (1997 - 2006)
  • Sandwich, GB (1999 - 2009)

Company Filing History:

goldMedal20 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 1990-2009

Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents
1. 7622500 - Antiparasitic agents (2009-11-24),
2. 7049444 - 3-azabicyclo[3.1.0]hexane derivatives useful in therapy (2006-05-23),
3. 7012083 - Compounds useful in therapy (2006-03-14),
4. 6812236 - Compounds useful in therapy (2004-11-02),
5. 6750231 - 4-arylpiperidine derivatives for the treatment of pruritus (2004-06-15),
6. 6610711 - 4-phenylpiperidines for the treatment of pruritic dermatoses (2003-08-26),
7. 6518282 - 4-Arylpiperidine derivatives for the treatment of pruritus (2003-02-11),
8. 6479516 - 4-arylpiperidine derivatives for the treatment of pruritus (2002-11-12),
9. 6441000 - Compounds useful in therapy (2002-08-27),
10. 6362168 - Antiparasitic agents (2002-03-26),
11. 6313312 - 3-Azabicyclo[3.1.0]hexane derivatives useful in therapy (2001-11-06),
12. 5883080 - Antiparastic auermectin derivatives (1999-03-16),
13. 5840704 - Antiparasitic agents and process for their preparation (1998-11-24),
14. 5702924 - Process for preparing antiparasitic agents (1997-12-30),
15. 5665708 - Process and antiparasitic intermediates for doramectin (1997-09-09),

Title: Stephen Paul Gibson - Innovator in Antiparasitic and Therapeutic Compounds

Introduction

Stephen Paul Gibson is a prominent inventor based in Sandwich, Great Britain. With an impressive portfolio of 20 patents, he has significantly contributed to the field of pharmaceutical innovations, particularly in the development of antiparasitic agents and therapeutic compounds.

Latest Patents

Among his latest inventions, one of the noteworthy patents focuses on antiparasitic agents, which includes compounds of a specific formula (I) and their pharmaceutically acceptable salts. This invention highlights the potential applications of these compounds in fighting parasitic infections. Another significant patent involves 3-azabicyclo[3.1.0]hexane derivatives, designed as opiate binding agents. These compounds, detailed by formula (I) along with their salts and prodrugs, are targeted for use in treating conditions related to opioid mediation. The patent also elaborates on the processes for synthesizing these valuable substances.

Career Highlights

Stephen’s career is closely tied to Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer has enabled him to push the boundaries of pharmaceutical research and innovation, leading to groundbreaking advancements in drug development.

Collaborations

In his innovative endeavors, Stephen collaborates with esteemed colleagues like Christopher J. Dutton and Ivan Tommasini. Their combined expertise not only amplifies their research efforts but also enriches the overall output of innovative solutions within the company.

Conclusion

With a robust array of patents and a dedicated career at Pfizer Corporation, Stephen Paul Gibson exemplifies the spirit of innovation in the pharmaceutical industry. His contributions in developing antiparasitic agents and therapeutic compounds illustrate his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…